GEMTESA 75 mg/1
vibegron · TABLET, FILM COATED · Sumitomo Pharma America, Inc.
Gemtesa (vibegron) is an oral tablet used to treat overactive bladder symptoms such as urge incontinence, urgency, and urinary frequency. It works by activating beta3-adrenergic receptors in the bladder muscle to help reduce these symptoms.
Key Facts
- Brand Name
- GEMTESA
- Generic Name
- vibegron
- NDC Code (Product)
73336-075- Manufacturer
- Sumitomo Pharma America, Inc.
- Strength
- 75 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA213006
- Drug Class
- beta3-Adrenergic Agonist [EPC]
- Marketing Start
- 12/29/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is GEMTESA used for?
Gemtesa (vibegron) is an oral tablet used to treat overactive bladder symptoms such as urge incontinence, urgency, and urinary frequency. It works by activating beta3-adrenergic receptors in the bladder muscle to help reduce these symptoms.
Is GEMTESA a controlled substance?
GEMTESA is not classified as a controlled substance by the DEA.
What is the generic name for GEMTESA?
The generic name for GEMTESA is vibegron. There are no other listed brand versions of vibegron.
What is the NDC code for GEMTESA 75 mg/1?
The NDC (National Drug Code) for GEMTESA 75 mg/1 is 73336-075, listed by Sumitomo Pharma America, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)